Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunitybio Inc
(NQ:
IBRX
)
4.095
-0.095 (-2.27%)
Streaming Delayed Price
Updated: 3:37 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,208,221
Open
4.180
Bid (Size)
4.090 (10)
Ask (Size)
4.100 (7)
Prev. Close
4.190
Today's Range
4.075 - 4.250
52wk Range
1.250 - 10.53
Shares Outstanding
391,156,513
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Top 3 Health Care Stocks That Are Set To Fly This Quarter
August 16, 2024
Via
Benzinga
Performance
YTD
-21.85%
-21.85%
1 Month
-24.59%
-24.59%
3 Month
-38.14%
-38.14%
6 Month
-10.78%
-10.78%
1 Year
+148.18%
+148.18%
More News
Read More
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
Via
InvestorPlace
How Is The Market Feeling About ImmunityBio?
May 17, 2024
Via
Benzinga
ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval
August 12, 2024
From
ImmunityBio, Inc.
Via
Business Wire
ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer
August 06, 2024
From
ImmunityBio, Inc.
Via
Business Wire
IMMUNITYBIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX
July 26, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Via
InvestorPlace
3 Top Cancer Treatment Stocks to Buy Now
July 17, 2024
Via
InvestorPlace
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
June 23, 2024
Via
Benzinga
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 20, 2024
Via
Benzinga
Why ImmunityBio Stock Is Trading Higher Thursday
June 20, 2024
Via
Benzinga
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
June 20, 2024
Via
Benzinga
ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors
June 20, 2024
From
ImmunityBio, Inc.
Via
Business Wire
3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions
June 20, 2024
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update
June 07, 2024
From
ImmunityBio, Inc.
Via
Business Wire
These 3 Interesting Stocks Are Seeing Heavy Short Interest In June 2024
June 04, 2024
Via
Talk Markets
Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
May 17, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months
May 13, 2024
Via
Talk Markets
IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024
May 10, 2024
Via
InvestorPlace
The 3 Best Bargain Stocks to Buy in May 2024
May 09, 2024
Via
InvestorPlace
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
May 07, 2024
Via
Benzinga
ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®
May 07, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.